公开(公告)号：US20230201163A1

公开(公告)日：2023-06-29

申请号：US18171126

申请日：2023-02-17

申请人： EA PHARMA CO., LTD.

发明人： Ayatoshi ANDO ,  Ippei KAWANISHI ,  Seiji SHIRAISHI ,  Harumi TANAKA ,  Yuki SAITOU

IPC分类号： A61K31/40 ,  A61P1/16

CPC分类号： A61K31/40 ,  A61P1/16

摘要： An object of the present invention is to provide a therapeutic agent for fatty liver diseases. The above object can be achieved by a therapeutic agent for a fatty liver disease, comprising a compound represented by the following formula (1):




or a pharmaceutically acceptable salt thereof.